Small Cell Lung Cancer in a 14-year-old Girl.

Håvard Trønnes; Hans Kristian Haugland; Albert Békássy; Svein Inge Helle; Halfdan Sorbye

doi:10.1097/MPH.0b013e31821f0ec4

Small Cell Lung Cancer in a 14-year-old Girl.

Håvard Trønnes, Hans Kristian Haugland, Albert Békássy, Svein Inge Helle, Halfdan Sorbye

Paediatrics (Lund)

Research output: Contribution to journal › Article › peer-review

Abstract

Pediatric lung cancer is uncommon, and small cell lung cancer (SCLC) is exceptionally rare. A 14-year-old previously healthy girl was diagnosed with limited-stage SCLC, which was considered inoperable. She responded well to chemotherapy with carboplatin and etoposide, and surgical resection was performed after 2 cycles. High-dose thoracic radiotherapy in combination with etoposide and carboplatin was given as postoperative treatment. The patient died of relapsing disease 21 months after initial diagnosis. Only 1 single case report on SCLC has been published earlier. Additional reports on pediatric SCLC are needed to evaluate appropriate treatment.

Original language	English
Pages (from-to)	E86-E88
Journal	Journal of Pediatric Hematology/Oncology
Volume	34
DOIs	https://doi.org/10.1097/MPH.0b013e31821f0ec4
Publication status	Published - 2012

Subject classification (UKÄ)

Pediatrics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/MPH.0b013e31821f0ec4

http://www.ncbi.nlm.nih.gov/pubmed/22031117?dopt=Abstract

Cite this

@article{8c8ef8e310b04ea8ba0b10df9d91589a,

title = "Small Cell Lung Cancer in a 14-year-old Girl.",

abstract = "Pediatric lung cancer is uncommon, and small cell lung cancer (SCLC) is exceptionally rare. A 14-year-old previously healthy girl was diagnosed with limited-stage SCLC, which was considered inoperable. She responded well to chemotherapy with carboplatin and etoposide, and surgical resection was performed after 2 cycles. High-dose thoracic radiotherapy in combination with etoposide and carboplatin was given as postoperative treatment. The patient died of relapsing disease 21 months after initial diagnosis. Only 1 single case report on SCLC has been published earlier. Additional reports on pediatric SCLC are needed to evaluate appropriate treatment.",

author = "H{\aa}vard Tr{\o}nnes and Haugland, {Hans Kristian} and Albert B{\'e}k{\'a}ssy and Helle, {Svein Inge} and Halfdan Sorbye",

year = "2012",

doi = "10.1097/MPH.0b013e31821f0ec4",

language = "English",

volume = "34",

pages = "E86--E88",

journal = "Journal of Pediatric Hematology/Oncology",

issn = "1536-3678",

publisher = "Lippincott Williams & Wilkins",

}

TY - JOUR

T1 - Small Cell Lung Cancer in a 14-year-old Girl.

AU - Trønnes, Håvard

AU - Haugland, Hans Kristian

AU - Békássy, Albert

AU - Helle, Svein Inge

AU - Sorbye, Halfdan

PY - 2012

Y1 - 2012

N2 - Pediatric lung cancer is uncommon, and small cell lung cancer (SCLC) is exceptionally rare. A 14-year-old previously healthy girl was diagnosed with limited-stage SCLC, which was considered inoperable. She responded well to chemotherapy with carboplatin and etoposide, and surgical resection was performed after 2 cycles. High-dose thoracic radiotherapy in combination with etoposide and carboplatin was given as postoperative treatment. The patient died of relapsing disease 21 months after initial diagnosis. Only 1 single case report on SCLC has been published earlier. Additional reports on pediatric SCLC are needed to evaluate appropriate treatment.

AB - Pediatric lung cancer is uncommon, and small cell lung cancer (SCLC) is exceptionally rare. A 14-year-old previously healthy girl was diagnosed with limited-stage SCLC, which was considered inoperable. She responded well to chemotherapy with carboplatin and etoposide, and surgical resection was performed after 2 cycles. High-dose thoracic radiotherapy in combination with etoposide and carboplatin was given as postoperative treatment. The patient died of relapsing disease 21 months after initial diagnosis. Only 1 single case report on SCLC has been published earlier. Additional reports on pediatric SCLC are needed to evaluate appropriate treatment.

U2 - 10.1097/MPH.0b013e31821f0ec4

DO - 10.1097/MPH.0b013e31821f0ec4

M3 - Article

C2 - 22031117

SN - 1536-3678

VL - 34

SP - E86-E88

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

ER -

Small Cell Lung Cancer in a 14-year-old Girl.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this